Evidence map›Paper›PMID 37231600›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda.

J Sung, A Musinguzi, J L Kadota, Y Baik, J Nabunje, F Welishe, O Bishop, C A Berger, A Katahoire, A Nakitende and 11 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 3 countries.

J SungDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
A MusinguziInfectious Diseases Research Collaboration, Kampala, Uganda.
J L KadotaDivision of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
Y BaikDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
J NabunjeInfectious Diseases Research Collaboration, Kampala, Uganda.
F WelisheInfectious Diseases Research Collaboration, Kampala, Uganda.
O BishopInfectious Diseases Research Collaboration, Kampala, Uganda.
C A BergerDivision of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
A KatahoireChild Health and Development Centre, Makerere University College of Health Sciences, Kampala, Uganda.
A NakitendeInfectious Diseases Research Collaboration, Kampala, Uganda.
J NakimuliInfectious Diseases Research Collaboration, Kampala, Uganda.
L AkelloInfectious Diseases Research Collaboration, Kampala, Uganda.
J R KasidiInfectious Diseases Research Collaboration, Kampala, Uganda.
L Kunihira TinkaUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
M R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda, Department of Internal Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
H SohnDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
N KiwanukaDepartment of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
A KatambaUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Department of Internal Medicine Clinical Epidemiology Unit, Makerere University College of Health Science, Kampala, Uganda.
A CattamanchiDivision of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA, USA.
D W DowdyUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
F C SemitalaInfectious Diseases Research Collaboration, Kampala, Uganda, Department of Internal Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda, Makerere University Joint AIDS Program, Kampala, Uganda.
Infectious Diseases Research Collaboration · UGMakerere University · UGUniversity of California, San Francisco · USJohns Hopkins Medicine · USJohns Hopkins University · USSan Francisco General Hospital · USSeoul National University · KRUniversity of Pennsylvania · US

Funding

RESEARCH TRAINING IN MICROBIAL DISEASEST32AI007291 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JOEL N BLANKSON, Sara Elizabeth Cosgrove · 1986 to 2026
$9.1M
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options TrialR01HL144406 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adithya Cattamanchi, David Wesley Dowdy · 2018 to 2026
$4.4M
NHLBI NIH HHS R01 HL144406NIAID NIH HHS T32 AI007291
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acquired Immunodeficiency SyndromeLatent TuberculosisTuberculosisAntitubercular AgentsDrug Therapy, CombinationFemaleHumansIsoniazidMaleRifampinUgandaAntitubercular AgentsIsoniazidRifampinrifapentine

Identifiers

PMID37231600
PMCPMC10316532
OpenAlexW4378348004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.